DrugPatentWatch Database Preview

Clavulanate potassium; ticarcillin disodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clavulanate potassium; ticarcillin disodium and what is the scope of freedom to operate?

Clavulanate potassium; ticarcillin disodium is the generic ingredient in two branded drugs marketed by Glaxosmithkline and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for clavulanate potassium; ticarcillin disodium.

Summary for clavulanate potassium; ticarcillin disodium

US Patents:	0
Tradenames:	2
Applicants:	1
NDAs:	3
Drug Master File Entries:	27
Clinical Trials:	1
DailyMed Link:	clavulanate potassium; ticarcillin disodium at DailyMed

Recent Clinical Trials for clavulanate potassium; ticarcillin disodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Phillip Brian Smith	Phase 1

See all clavulanate potassium; ticarcillin disodium clinical trials

US Patents and Regulatory Information for clavulanate potassium; ticarcillin disodium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaxosmithkline	TIMENTIN IN PLASTIC CONTAINER	clavulanate potassium; ticarcillin disodium	INJECTABLE;INJECTION	050658-001	Dec 15, 1989		DISCN	No	No
Glaxosmithkline	TIMENTIN	clavulanate potassium; ticarcillin disodium	INJECTABLE;INJECTION	050590-001	Apr 1, 1985		DISCN	No	No
Glaxosmithkline	TIMENTIN	clavulanate potassium; ticarcillin disodium	INJECTABLE;INJECTION	050590-002	Apr 1, 1985		DISCN	No	No
Glaxosmithkline	TIMENTIN	clavulanate potassium; ticarcillin disodium	INJECTABLE;INJECTION	050590-003	Aug 18, 1987		DISCN	No	No
Glaxosmithkline	TIMENTIN	clavulanate potassium; ticarcillin disodium	INJECTABLE;INJECTION	062691-001	Dec 19, 1986		DISCN	No	No